Together, these findings show that METTL3’s effects on NAFLD are still controversial, and additional research is needed to understand the biological functions and mechanisms of METTL3 in NAFLD. This evidence concerns the gene METTL3 and metabolic dysfunction-associated steatotic liver disease.